-
Board Certification
American Board of OphthalmologyPatient Rating
4.8 /5( out of 289 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
June 24, 2025MIDVALLEYDr. Sravanthi Vegunta is one of the best doctors I have ever been to. She listens to you and makes you feel that you matter. She has changed my life. I can't thank her enough. The people at the Moran Eye Center are very helpful and kind. I would recommend Dr. Vegunta to anyone I know. Thanks again.
June 19, 2025PRIMARY CHILDREN'S MEDICAL CENTERShe was very patient with me and answered all my questions.
June 16, 2025MIDVALLEYDr. Vegunta listened carefully to my recapping the history of my vision issue. She provided a detailed examination of my vision impairment and placed me at reasonable ease concerning the possible outcome of any corrective surgeries. I left the session with greater hope for a better quality of life.
June 13, 2025EXTERNAL SITEVery sweet, fun and a professional!
June 11, 2025EXTERNAL SITEAlways appreciate Dr Vagunta"s complete approach, knowledge, concern & conservative options.
June 08, 2025PRIMARY CHILDREN'S MEDICAL CENTERDr. Vegunta was professional and kind. She truly listened with intent and care and made us feel like what we experienced mattered.
June 08, 2025MIDVALLEYI researched a doctor to treat my blepharospasm and found Dr. Vegunta. She is a neuro-ophthalmologist at Moran and sees patients by referral only. I arranged for my ophthalmologist (Dr. Brian Rose, another good doctor) to refer me to Dr. Vegunta. Totally great experience so far. She has seen me once and we had a phone call to see how her treatment plan was working. I will be seeing her again for the next phase of treatment. Great experience to be provided care by Dr. Vegunta.
June 04, 2025MIDVALLEYDr Vegunta is an excellent problem solver! I am grateful for her compassion and knowledge. My vision has been challenging since my TBI and Dr Vegunta is determined to find a correction for me.
May 24, 2025EXTERNAL SITEI will wait for the next visit/surgery before completing.
-
Board Certification and Academic Information
Academic Departments Ophthalmology & Visual Sciences -Assistant Professor (Clinical)
Board Certification American Board of OphthalmologyEducation history
Fellowship Pediatric Ophthalmology - Indiana University School of Medicine, Riley Hospital for Children Fellow Fellowship Neuro-ophthalmology - University of Utah School of Medicine Fellow Residency Ophthalmology - University of Utah School of Medicine Chief Resident Residency Ophthalmology - University of Utah School of Medicine Resident Residency Internal Medicine - University of Utah School of Medicine Resident Professional Medical Medicine - University of Arizona College of Medicine-Phoenix M.D. Undergraduate Biology - Barrett Honors College at Arizona State University B.S. Undergraduate Biological Sciences - Pennoni Honors College - Drexel University B.S., M.D. Selected Publications
Journal Article
- Banwell E, York D, Vegunta S, Torr C, Yoder BA (2025). Can We Optimize Retinopathy of Prematurity Screening by Combined Risk Score Analysis? J Pediatr, 282, 114544. ()
- Hoshina Y, Seay M, Vegunta S, Stulberg EL, Wright MA, Wong KH, Smith TL, Shimura D, Clardy SL (2024). Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a US Mountain West Cohort. J Neuroophthalmol, 45(1), 36-43. ()
- Baugh BT, Digre KB, Seay MD, Warner JEA, Vegunta S (2024). A Case of Irreversible Optic Neuropathy Associated With Encorafenib/Binimetinib Therapy in a Patient With Metastatic Melanoma. J Neuroophthalmol. ()
- Vegunta S, Jensen MS (2023). Workup and Management of Idiopathic Intracranial Hypertension. J Womens Health (Larchmt), 33(1), 10-13. ()
- Peralta EA, Swiston CJ, Wiggins RH, Warner JEA, Vegunta S (2022). Temporal Lobe Encephalocele in a Patient With Suspected IIH: A Case Report. J Neuroophthalmol, 43(4), e173-e174. ()
- Modersitzki NK, Randall DJ, Vegunta S, Seay MD (2022). Novel Report of Ophthalmoparesis Associated With CMT Type 2P Secondary to LRSAM1 Mutation. J Neuroophthalmol, 43(4), e296-e297. ()
- Brady T, Vegunta S, Crum AV, Marx D, Patel BCK, Seay MD, Schmidt RH, Warner JEA, Digre KB, Katz BJ (2022). Interdisciplinary Protocol for the Management of Vision-Threatening Papilledema. J Neuroophthalmol, 42(4), 495-501. ()
- Wilkinson SW, Etheridge T, Swiston CJ, Vegunta S, Wiggins RH, Warner JEA (2021). Bilateral Posterior Cerebral Artery Stroke from COVID-Related Multisystem Inflammatory Syndrome in a Child. J Neuroophthalmol, 42(3), e548-e550. ()
- Randall DJ, Modersitzki NK, Vegunta S, Seay MD (2022). Optic Disc Edema Associated With Ustekinumab Therapy. J Neuroophthalmol, 44(1), e32-e33. ()
- Brady ST, Vegunta S, Olson LM, Brintz BJ, Pettey JH, Jardine GJ (2022). A Double-Flipped Virtual Classroom Format for Medical Students Learning Ophthalmology: An Approach to Clinical Rotations in the Context of COVID-19. J Acad Ophthalmol (2017), 14(1), e18-e22. ()
- Vegunta S, Bohnsack J, Crum A, Digre K, Katz B, Seay M, Quigley E, Kennedy S, Mamalis N, Warner J (2021). Multiple Cranial Neuropathies and Pachymeningitis in a Patient With a Pathogenic Nucleotide-Binding Oligomerization Domain 2 Polymorphism. J Neuroophthalmol, 41(4), 547-552. ()
- Jebaraj A, Warner J, Pettey J, Jardine G, Vegunta S (2021). Ophthalmology Residency Virtual Interviews in the Setting of the COVID-19 Pandemic: Perspectives of Applicants, Selection Committee Members, and Current Residents. J Acad Ophthalmol (2017), 13(2), e170-e174. ()
- Stiefel HC, Kopplin LJ, Albini T, Chang M, Vegunta S, Suhler EB (2019). Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Chart Review. Ocul Immunol Inflamm, 29(3), 566-571. ()
- Orme DR, Vegunta S, Miller MA, Warner JEA, Bair C, McFadden M, Crum AV, Digre KB, Katz BJ (2020). A Comparison Between the Clinical Features of Pseudotumor Cerebri Secondary to Tetracyclines and Idiopathic Intracranial Hypertension. Am J Ophthalmol, 220, 177-182. ()
- Ronquillo CC, Vegunta S, Ellis N, Mamalis N, Patel BCK (2020). Adenoid Cystic Carcinoma of the Eyelid Can Locally Recur and Mimic Basal Cell Carcinoma: Case Report and Review of the Literature. Ophthalmic Plast Reconstr Surg, 36(5), e112-e116. ()
- Xue W, Vegunta S, Zwart CM, Aguilar MI, Patel AC, Hoxworth JM, Demaerschalk BM, Mitchell JR (2017). Retrospective Validation of a Computer-Assisted Quantification Model of Intracerebral Hemorrhage Volume on Accuracy, Precision, and Acquisition Time, Compared with Standard ABC/2 Manual Volume Calculation. AJNR Am J Neuroradiol, 38(8), 1536-1542. ()
- Enslow R, Bhuvanagiri S, Vegunta S, Cutler B, Neff M, Stagg B (2016). Association of Anti-VEGF Injections with Progression of Geographic Atrophy. Ophthalmol Eye Dis, 8, 31-2. ()
- Vegunta S, Patel D, Shen JF (2016). Combination Therapy of Intense Pulsed Light Therapy and Meibomian Gland Expression (IPL/MGX) Can Improve Dry Eye Symptoms and Meibomian Gland Function in Patients With Refractory Dry Eye: A Retrospective Analysis. Cornea, 35(3), 318-22. ()
- Vegunta S, Cotugno R, Williamson A, Grebe TA (2015). Chronic pain in Noonan Syndrome: A previously unreported but common symptom. Am J Med Genet A, 167A(12), 2998-3005. ()
Review
- Vegunta S, Patel BC (2020). Optic Nerve Coloboma. [Review]. ()
- Vegunta S, Patel BC (2020). Optic Nerve Cysts. [Review]. ()
-
News & Podcasts
( out of 289 reviews )